Saturday, July 11, 2026

Drug profile · INN

ferric oxyhydroxide

ferric oxyhydroxide (VELPHORO) is a phosphate sequestering agent. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — ferric oxyhydroxide
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

ferric oxyhydroxide (VELPHORO) is a phosphate sequestering agent. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN ferric oxyhydroxide
Brand VELPHORO
Mechanism Phosphate sequestering agent
Target Phosphate
Route ORAL
Formulation TABLET, CHEWABLE

Mechanism of action

Phosphate sequestering agent

Primary target: Phosphate

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. alendronate sodium Farnesyl diphosphate synthase inhibitor
  2. calcium acetate Phosphate sequestering agent
  3. ferric citrate Phosphate sequestering agent
  4. ferric citrate coordination complex Various (V03)
  5. fingolimod hydrochloride Sphingosine 1-phosphate receptor agonist
  6. fingolimod lauryl sulfate Sphingosine 1-phosphate receptor binding agent

Frequently asked questions

What is ferric oxyhydroxide?

ferric oxyhydroxide (VELPHORO) is a phosphate sequestering agent. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for ferric oxyhydroxide?

VELPHORO is a marketed brand name for ferric oxyhydroxide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ferric oxyhydroxide?

ferric oxyhydroxide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.